Reply to: “Understanding virologic heterogeneity in chronic hepatitis B treatment”
Matthews PC. et al, (2025), JHEP Reports, 7, 101280 - 101280
Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos/tide analogue therapy
Wang T. et al, (2024), JHEP Reports, 101229 - 101229
Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?
Campbell C. et al, (2023), Wellcome Open Research, 7, 203 - 203
Cohort Profile: The National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) research dataset
Wang T. et al, (2023), International Journal of Epidemiology, 52, e27 - e37
Bone mineral density and fractures in patients with rheumatoid arthritis: the DXA-HIP project.
Ebrahimiarjestan M. et al, (2023), Rheumatology advances in practice, 7
Distinct virologic trajectories in chronic hepatitis B patients identify heterogeneity in response to nucleotide analogue therapy
Wang T. et al, (2023), JOURNAL OF HEPATOLOGY, 78, S1075 - S1076
Transforming unstructured digital clinical notes for improved health literacy
Doppalapudi S. et al, (2022), Digital Transformation and Society, 1, 9 - 28
Impact of the COVID-19 pandemic on routine surveillance for adults with chronic hepatitis B virus (HBV) infection in the UK.
Campbell C. et al, (2022), Wellcome open research, 7